Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Exercise × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Gastrointestinal 1

Conditions

Motor Activity 28 Colorectal Neoplasms 24 Colonic Neoplasms 15 Neoplasms 11 Pancreatic Neoplasms 10 Rectal Neoplasms 9 Breast Neoplasms 9 Stomach Neoplasms 6 Esophageal Neoplasms 5 Prostatic Neoplasms 4 Liver Neoplasms 3 Postoperative Complications 2 Ovarian Neoplasms 2 Lung Neoplasms 2 Gastrointestinal Neoplasms 2 Weight Loss 1 Urinary Incontinence 1 Thyroid Neoplasms 1 Sexual Dysfunction, Physiological 1 Sarcopenia 1 Risk Reduction Behavior 1 Psychological Well-Being 1 Peripheral Nervous System Diseases 1 Patient Compliance 1 Pancreas Adenocarcinoma 1 Obesity 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mesothelioma 1 Malabsorption Syndromes 1

Interventions

Fluorouracil 98 Oxaliplatin 94 Leucovorin 86 Irinotecan 69 Gemcitabine 66 Bevacizumab 62 Capecitabine 60 Cetuximab 42 pembrolizumab 37 Cisplatin 30 Drug Therapy 25 Nivolumab 24 130-nm albumin-bound paclitaxel 22 Folfox protocol 21 Panitumumab 19 Specimen Handling 18 Paclitaxel 18 Magnetic Resonance Spectroscopy 17 Albumin-Bound Paclitaxel 17 Biopsy 16 IFL protocol 15 Floxuridine 15 Sorafenib 14 Docetaxel 14 Cyclophosphamide 14 regorafenib 12 Erlotinib Hydrochloride 12 aflibercept 11 Radiofrequency Ablation 11 Carboplatin 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02162914 2020-07-31

REACHIN

Erasme University Hospital

Phase 2 Unknown

Gastrointestinal

Neoplasm Metastasis, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡